Welcome to Visited Lingnan Modern Clinics In Surgery, Today is

Lingnan Modern Clinics in Surgery ›› 2018, Vol. 18 ›› Issue (05): 579-581.DOI: 10.3969/j.issn.1009-976X.2018.05.020

Previous Articles     Next Articles

The clinical feasibility of transurethral plasmakinetic enucleation of prostate in treatment of large benign prostatic hyperplasia

SU Bin,FANG Jianning,WU Miaofeng,QIU Zhiyong,LAN Yansi,CHEN Kang   

  1. Department of Urological Surgery,Huidong People′s Hospitaql,Huizhou,Guangdong

PKEP 治疗巨大良性前列腺增生的基层医院经验

苏斌,方建宁,吴妙锋,邱志勇,蓝燕思,陈康   

  1. 惠东县人民医院
  • 通讯作者: 苏斌

Abstract: [Abstract] Objective To investigate the curative effect of transurethral plasmakinetic enucleation for treatment of large benign prostatic hyperplasia. Methods Forty?five cases of huge benign prostatic hyperplasia patients from March 2016 to March 2017 were assigned to two groups, PKRP group(treated with plasmakinetie resection of the prostate, n=22)and PKEP group(treated with plasma kinetic enucleation of the prostate, n=23). The related clinical indicators were recorded and compared between two groups. Results There was no significant difference between the two groups in operation time (t=1.132, P>0.05). The PKEP group had more prostate tissue resection than PKRP group(t=3.462, P< 0.01), and the intraoperative blood loss was reduced(t=5.395, P<0.01), and no perforation occurred in the PKEP group. After 3 months of follow?up, the IPS and QOL of the two groups decreased significantly, and the residual urine decreased significantly. The IPSS and QOL of PKEP group were significantly lower than of PKRP group, and the difference was statistically significant(t=2.093, P<0.05;t=2.761, P<0.01). There was no significant difference in PVR and hospitalization time between the two groups(P>0.05). Conclusion Compared with PKRP, PKEP can excise more effective benign prostatic hyperplasia, has less intraoperative bleeding, and is a safer surgical approach.

Key words: transurethral plasmakinetic enucleation of prostate, feasibility, transurethral resection of the prostate, benign prostatic hyperplasia

摘要: [摘要]目的 探讨经尿道等离子剜除术治疗巨大良性前列腺增生的临床经验。方法 将2016年3月至2017年3月我科收治的45例巨大前列腺增生患者分为两组,分别应用经尿道前列腺等离子剜除术(PKEP组)23例和经尿道等离子前列腺电切术(PKRP组)22例进行治疗,对比两组的相关临床指标。结果 两组手术时间相比,差异无统计学意义(t=1.132,P>0.05)。PKEP组切除前列腺组织较PKRP组更多(t=3.462,P<0.01),且术中出血量减少(t=5.395,P<0.01),且PKEP组未出现穿孔发生。随访3个月两组IPSS及QOL明显下降,残余尿明显减少。PKEP组IPSS及QOL显著低于PKRP组,差异具有统计学意义(t=2.093,P<0.05;t=2.761,P<0.01)。两组PVR差异则无统计学意义,住院时间也无显著差异(P>0.05)。结论 与PKRP相比,PKEP可切除更多前列腺增生组织,术中出血少,手术更安全。

关键词: 经尿道等离子前列腺电切术, 经尿道双极等离子前列腺剜除术, 巨大良性前列腺增生

CLC Number: